These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14692656)

  • 1. Potent killing of paclitaxel- and doxorubicin-resistant breast cancer cells by calphostin C accompanied by cytoplasmic vacuolization.
    Guo B; Hembruff SL; Villeneuve DJ; Kirwan AF; Parissenti AM
    Breast Cancer Res Treat; 2003 Nov; 82(2):125-41. PubMed ID: 14692656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
    Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells.
    Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D
    Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells.
    Ehrlichová M; Koc M; Truksa J; Naldová Z; Václavíková R; Kovárr J
    Anticancer Res; 2005; 25(6B):4215-24. PubMed ID: 16309219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.
    Chadderton A; Villeneuve DJ; Gluck S; Kirwan-Rhude AF; Gannon BR; Blais DE; Parissenti AM
    Breast Cancer Res Treat; 2000 Feb; 59(3):231-44. PubMed ID: 10832593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
    Park SJ; Wu CH; Safa AR
    Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure.
    Guo B; Villeneuve DJ; Hembruff SL; Kirwan AF; Blais DE; Bonin M; Parissenti AM
    Breast Cancer Res Treat; 2004 May; 85(1):31-51. PubMed ID: 15039596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis.
    Chen JS; Konopleva M; Andreeff M; Multani AS; Pathak S; Mehta K
    J Cell Physiol; 2004 Aug; 200(2):223-34. PubMed ID: 15174092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
    Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C; Ferreira CG; Bröker LE; Rodriguez JA; Smit EF; Postmus PE; Kruyt FA; Giaccone G
    Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride.
    Chen YY; Li ZZ; Ye YY; Xu F; Niu RJ; Zhang HC; Zhang YJ; Liu YB; Han BS
    BMC Mol Biol; 2016 Mar; 17():6. PubMed ID: 26935744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.
    Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD
    Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.
    Kovár J; Ehrlichová M; Smejkalová B; Zanardi I; Ojima I; Gut I
    Anticancer Res; 2009 Aug; 29(8):2951-60. PubMed ID: 19661300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
    Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
    Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
    Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
    BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.